Total Payments
$4,259
2024 Payments
$1,545
Companies
39
Transactions
286
Medicare Patients
577
Medicare Billing
$37,737
Payment Breakdown by Category
Food & Beverage$4,244 (99.6%)
Other$15.00 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,244 | 285 | 99.6% |
| Honoraria | $15.00 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,780 | 129 | $0 (2024) |
| Lundbeck LLC | $291.57 | 16 | $0 (2024) |
| Lilly USA, LLC | $233.09 | 16 | $0 (2024) |
| Novo Nordisk Inc | $211.08 | 15 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $177.89 | 8 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $165.43 | 16 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $118.27 | 6 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $96.52 | 7 | $0 (2024) |
| PFIZER INC. | $92.61 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $90.70 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,545 | 100 | ABBVIE INC. ($616.20) |
| 2023 | $1,257 | 79 | ABBVIE INC. ($542.85) |
| 2022 | $884.89 | 66 | ABBVIE INC. ($322.96) |
| 2021 | $572.16 | 41 | AbbVie Inc. ($297.85) |
All Payment Transactions
286 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: Obesity | ||||||
| 12/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: UROLOGY | ||||||
| 12/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.34 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.08 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $9.28 | General |
| Category: Obesity | ||||||
| 12/05/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/19/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.55 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $23.20 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $8.32 | General |
| Category: Obesity | ||||||
| 10/29/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.88 | General |
| Category: NEUROLOGY | ||||||
| 10/18/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Obesity | ||||||
| 10/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Obesity | ||||||
| 10/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Cardio-renal | ||||||
| 07/12/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.06 | General |
| Category: PSYCHIATRY | ||||||
| 07/03/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 125 | 178 | $17,586 | $8,268 |
| 2022 | 2 | 140 | 213 | $20,983 | $9,841 |
| 2021 | 3 | 167 | 236 | $23,811 | $12,589 |
| 2020 | 2 | 145 | 220 | $19,580 | $7,039 |
Total Patients
577
Total Services
847
Medicare Billing
$37,737
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 80 | 122 | $12,322 | $6,305 | 51.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 45 | 56 | $5,264 | $1,962 | 37.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 76 | 132 | $13,369 | $6,954 | 52.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 64 | 81 | $7,614 | $2,887 | 37.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 71 | 121 | $12,599 | $6,951 | 55.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 78 | 94 | $7,876 | $3,747 | 47.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 18 | 21 | $3,336 | $1,891 | 56.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 66 | 110 | $11,880 | $4,408 | 37.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 79 | 110 | $7,700 | $2,631 | 34.2% |
About Patty Fleming, CNP
Patty Fleming, CNP is a Family healthcare provider based in Ontario, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2017. The National Provider Identifier (NPI) number assigned to this provider is 1679095798.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Patty Fleming, CNP has received a total of $4,259 in payments from pharmaceutical and medical device companies, with $1,545 received in 2024. These payments were reported across 286 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($4,244).
As a Medicare-enrolled provider, Fleming has provided services to 577 Medicare beneficiaries, totaling 847 services with total Medicare billing of $37,737. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Ontario, OH
- Active Since 07/11/2017
- Last Updated 12/29/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1679095798
Products in Payments
- UBRELVY (Drug) $708.53
- VRAYLAR (Drug) $467.79
- REXULTI (Drug) $374.00
- QULIPTA (Drug) $336.23
- NURTEC ODT (Drug) $242.75
- JARDIANCE (Drug) $162.01
- LINZESS (Drug) $129.25
- SPRAVATO (Drug) $106.70
- VIBERZI (Drug) $98.97
- Kerendia (Drug) $96.52
- VYEPTI (Biological) $95.46
- Wegovy (Drug) $94.16
- GEMTESA (Drug) $88.17
- GVOKE HYPOPEN (Drug) $82.03
- TRINTELLIX (Drug) $77.17
- BREZTRI (Drug) $57.13
- VOQUEZNA (Drug) $55.92
- LEQVIO (Drug) $47.79
- Ozempic (Drug) $45.34
- Tymlos (Drug) $45.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Ontario
Amber Campbell, Cnp, CNP
Family — Payments: $8,036
Family $8,036
Natalie Roby, N.p, N.P
Family — Payments: $5,161
Family $5,161
Mrs. Julie Burkhart, Aprn, Np-C, APRN, NP-C
Family — Payments: $3,466
Family $3,466
Kiersten Hogg, Dnp, Fnp, DNP, FNP
Family — Payments: $2,728
Family $2,728
Mr. Michael Conley, Np, NP
Family — Payments: $2,477
Family $2,477
Martha Ruiz, Fnp, FNP
Family — Payments: $1,843
Family $1,843